Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02782065 · ClinicalTrials.gov registry record

Validation of the Hospital Asthma Severity Score (HASS)

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
58
Enrollment target

NCT02782065 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 58 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02782065 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
58 participants
Enrollment target

Study Summary

The purpose of this research will be to evaluate the reliability and validity of the HASS tool in a cohort of patients' ages 7 to18 years old against the gold standard of spirometry, and in ages 2 to 6 against spirometry, if possible, and the most similar validated tool, the PRAM.

Interventions

  • OTHER Not an interventional study

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2016-09-29
Est. Completion 2020-01

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT02782065

The ClinicalTrials.gov registry entry for NCT02782065 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Not an interventional study is the first listed.

NCT02782065 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02782065 about?

NCT02782065 is a clinical study titled "Validation of the Hospital Asthma Severity Score (HASS)". The purpose of this research will be to evaluate the reliability and validity of the HASS tool in a cohort of patients' ages 7 to18 years old against the gold standard of spirometry, and in ages 2 to 6 against spirometry, if possible, and the most similar validated tool, the PRAM.

What is the current status of trial NCT02782065?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2016-09-29. Estimated completion is 2020-01.

What interventions are being tested in trial NCT02782065?

The interventions under investigation include: Not an interventional study (OTHER).

Who is sponsoring clinical trial NCT02782065?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.